At a glance
- Originator ASTA Medica [CEASED]
- Class Class III antiarrhythmics; Oxalates
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 01 Dec 2002 Discontinued - Preclinical for Arrhythmias in Russia (unspecified route)
- 07 Feb 2000 Discontinued-Preclinical for Arrhythmias in Germany (Unknown route)
- 07 Feb 2000 Preclinical development for Arrhythmias in Russia (Unknown route)